---
title: HUB Organoids for personalized medicine at PHB seminar series
description: Our CEO Robert Vries talks about the applications of organoids to personalized medicine
image: https://resources.huborganoids.nl/hubfs/SocialMedia-ISSCR.jpg
---

[![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")](https://huborganoids.nl/)

![merk-m-logo-blue](https://resources.huborganoids.nl/hs-fs/hubfs/merk-m-logo-blue.png?width=728&height=225&name=merk-m-logo-blue.png)

# On demand presentation

HUB Organoids® as unique tools for personalized medicine

### Get the right drug to the right patient population

### Talk highlights

![glimpse of Personal Health Basel Seminar series](https://resources.huborganoids.nl/hs-fs/hubfs/LandingPage-PHBSeminar-image.jpg?width=400&name=LandingPage-PHBSeminar-image.jpg)Personalized medicine holds great promise for the future of patient treatment, offering the opportunity to refine our understanding of risk/benefits of a new treatment and identify subsets of patients that are more likely to respond based on pharmacogenomic data.

HUB Organoids have contributed to recent approvals of a new drug to treat cystic fibrosis based on a personalized medicine approach and are actively supporting preclinical precision medicine programs in several other therapeutic areas.

In this presentation Dr. Rob Vries, CEO:

- Describes current progress in the field of personalized medicine
- Reviews data on HUB Organoids applications as powerful tools to predict patient response
- Identifies outstanding challenges such as new trial designs in personalized medicine
- Discusses what evidences may still be needed for the approval of organoids as *in vitro* diagnostic tools

### Watch our presentation

![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")

[Privacy Policy](https://huborganoids.nl/privacy-policy)

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

***FOR RESEARCH USE ONLY.**  Unless otherwise stated in our catalog or other company documentation  
 accompanying the product(s), our products are intended for research use only and are not to be used   
 for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro   
 diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to   
humans or animals.*